These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30728609)

  • 41. International collaboration and covid-19: what are we doing and where are we going?
    Bump JB; Friberg P; Harper DR
    BMJ; 2021 Jan; 372():n180. PubMed ID: 33509953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Commercial influence in control of non-communicable diseases.
    Whitaker K; Webb D; Linou N
    BMJ; 2018 Jan; 360():k110. PubMed ID: 29330159
    [No Abstract]   [Full Text] [Related]  

  • 43. Editorial.
    Henning K
    Health Educ Res; 2018 Feb; 33(1):1-3. PubMed ID: 29562269
    [No Abstract]   [Full Text] [Related]  

  • 44. Experiences from the pilot implementation of the Package of Essential Non-communicable Disease Interventions (PEN) in Myanmar, 2017-18: A mixed methods study.
    Aye LL; Tripathy JP; Maung Maung T; Oo MM; Nwe ML; Thu HMM; Ko K; Kaung KK
    PLoS One; 2020; 15(2):e0229081. PubMed ID: 32069323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustainable partnerships for NCD prevention: implications for public health.
    Di Ruggiero E; Leung Z; Mwatsama M; Hallen G
    Int J Public Health; 2018 Jun; 63(5):553-554. PubMed ID: 29766206
    [No Abstract]   [Full Text] [Related]  

  • 46. Port-of-Spain Declaration for global NCD prevention.
    Chattu VK; Sakhamuri S
    Lancet; 2018 Apr; 391(10131):1682. PubMed ID: 29726343
    [No Abstract]   [Full Text] [Related]  

  • 47. Addressing cancer prevention and control in Armenia: tobacco control and mHealth as key strategies.
    Berg CJ; Harutyunyan A; Paichadze N; Hyder AA; Petrosyan V
    Int J Equity Health; 2021 Jan; 20(1):4. PubMed ID: 33407461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Life course approach to prevention and control of non-communicable diseases.
    Mikkelsen B; Williams J; Rakovac I; Wickramasinghe K; Hennis A; Shin HR; Farmer M; Weber M; Berdzuli N; Borges C; Huber M; Breda J
    BMJ; 2019 Jan; 364():l257. PubMed ID: 30692103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stop industry interference, save lives.
    The Lancet Global Health
    Lancet Glob Health; 2019 Dec; 7(12):e1584. PubMed ID: 31708127
    [No Abstract]   [Full Text] [Related]  

  • 50. Global Health diplomacy for noncommunicable diseases prevention and control: a systematic review.
    Afshari M; Ahmadi Teymourlouy A; Asadi-Lari M; Maleki M
    Global Health; 2020 May; 16(1):41. PubMed ID: 32375804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curbing the lifestyle disease pandemic: making progress on an interdisciplinary research agenda for law and policy interventions.
    Toebes B; Hesselman M; van Dijk JP; Herman J
    BMC Int Health Hum Rights; 2017 Sep; 17(1):25. PubMed ID: 28923078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the verge of a chronic disease epidemic: comprehensive policies and actions are needed in Indonesia.
    Kusuma D; Kusumawardani N; Ahsan A; K Sebayang S; Amir V; Ng N
    Int Health; 2019 Nov; 11(6):422-424. PubMed ID: 31294789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using economic evidence to support policy decisions to fund interventions for non-communicable diseases.
    Bertram M; Banatvala N; Kulikov A; Belausteguigoitia I; Sandoval R; Hennis A; Webb D; Tarlton D
    BMJ; 2019 May; 365():l1648. PubMed ID: 31110025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fiscal austerity measures hamper noncommunicable disease control goals in Brazil.
    Malta DC; Duncan BB; Barros MBA; Katikireddi SV; Souza FM; Silva AGD; Machado DB; Barreto ML
    Cien Saude Colet; 2018 Oct; 23(10):3115-3122. PubMed ID: 30365830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reimagining Development Assistance for Health.
    Gupta V; Katz R; Swaminathan S
    N Engl J Med; 2018 Nov; 379(20):1891-1893. PubMed ID: 30256712
    [No Abstract]   [Full Text] [Related]  

  • 56. Addressing non-communicable diseases in disaster risk reduction - an issue of equity.
    Gnanapragasam S; Aitsi-Selmi A; Rashbrook E; Murray V
    J Epidemiol Glob Health; 2016 Jun; 6(2):119-21. PubMed ID: 27001076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opportunities and challenges of global health diplomacy for prevention and control of noncommunicable diseases: a systematic review.
    Asadi-Lari M; Ahmadi Teymourlouy A; Maleki M; Afshari M
    BMC Health Serv Res; 2021 Nov; 21(1):1193. PubMed ID: 34736461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Public Health Round-up.
    Bull World Health Organ; 2018 Nov; 96(11):732-733. PubMed ID: 30455526
    [No Abstract]   [Full Text] [Related]  

  • 59. Capacity to control noncommunicable diseases in the countries of South-East Asia.
    Leowski J; Krishnan A
    Health Policy; 2009 Sep; 92(1):43-8. PubMed ID: 19304337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trade challenges at the World Trade Organization to national noncommunicable disease prevention policies: A thematic document analysis of trade and health policy space.
    Barlow P; Labonte R; McKee M; Stuckler D
    PLoS Med; 2018 Jun; 15(6):e1002590. PubMed ID: 29944652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.